Ten times a year, the LISAvienna newsletter keeps you updated on news from the Vienna based life sciences community as well as on funding opportunities and events.
This time our news review includes success stories from Arsanis, Eucodis, Evercyte, mySugr, Piur Imaging, Scarletred, TAmiRNA, Technoclone and Viravaxx. In addition, we draw your attention to some academic publications that hit the headlines recently.
Furthermore, we highlight relevant events in Vienna and international trade fairs and partnering meetings in our newsletter. Up-to-date information on funding opportunities and links to the spring edition of our biannual Highlights publication and to the registration form for our business meeting on medical devices on March 29 are also included.